Sara Bonstein, Chief Financial Officer at INSMED Inc (INSM), sold 35,944 shares at $80.28 ($2.9M) on 2025-02-18, disclosed to the SEC on 2025-02-20.
Scheduled sale ($2.9M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.28 | 17,622 | $1.4M | 49.0% |
| 2 | $80.28 | 17,622 | $1.4M | 49.0% |
| 3 | $81.00 | 700 | $57K | 2.0% |
| Total | $80.29 avg | 35,944 | $2.9M | 100% |
| Filing → |
| INSM | SELL | 2026-02-04 | $117K | — | Filing → |
| INSM | SELL | 2026-01-08 | $809K | — | Filing → |
| INSM | SELL | 2025-07-23 | $12.0M | — | Filing → |